Overview Financials News + Filings Key Docs Ownership Insiders |
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 |
Revenues | 44.8 | 34.6 | 0.0 | 19.8 | 0.0 |
Revenue growth | | 75.2% | | | |
Cost of goods sold | 0.0 | 44.8 | 0.0 | 27.8 | 0.0 |
Gross profit | 44.8 | -10.2 | 0.0 | -8.1 | 0.0 |
Gross margin | 100.0% | -29.3% | | -40.8% | |
Research and development | 34.6 | | 19.8 | | 4.6 |
General and administrative | 10.2 | 10.2 | 8.1 | 8.1 | 9.8 |
EBIT | -44.8 | -44.8 | -27.8 | -27.8 | -14.4 |
EBIT margin | -100.0% | -129.3% | | -140.8% | |
Pre-tax income | -43.9 | -43.9 | -27.8 | -27.8 | -14.4 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net income | -43.9 | -43.9 | -27.8 | -27.8 | -14.4 |
Net margin | -98.1% | -126.9% | | -140.6% | |
|
Diluted EPS | ($2.56) | ($2.56) | ($1.93) | ($1.93) | ($3.78) |
Shares outstanding (diluted) | 17.2 | 17.2 | 14.4 | 14.4 | 3.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|